新博n88老虎机_新博n88手机_新博国际娱乐平台

  • <strike id="qzkqg"></strike>

    <strike id="qzkqg"></strike>

    <strike id="qzkqg"></strike>
    <th id="qzkqg"><sup id="qzkqg"></sup></th>
    <object id="qzkqg"></object>

    <tr id="qzkqg"></tr>
    Research And Development Pipeline

    Zenshine’s drug discovery and development programs involve targeting purinergic signaling in immune cells and intracellular signal transduction pathways to modulate tumor microenvironment and thus to promote immunity. ZX-101 is now at preclinical development stage. Clinical trial for ZX-101 is expected to be initiated early 2020. We also have multiple programs at discovery stage. 

    新博n88老虎机_新博n88手机_新博国际娱乐平台